PREventative Study Against URate-lowering Drug-induced Gout Exacerbations 1

ClinicalTrials.gov ID: NCT00829829

Public ClinicalTrials.gov record NCT00829829. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 21, 2026, 7:27 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of Rilonacept for the Prophylaxis of Gout Flares During the Initiation of Allopurinol Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this clinical research study was to determine the safety and effectiveness of an experimental drug called rilonacept in subjects with gout who are beginning allopurinol treatment for gout. Subjects will participate in this study for approximately 22 weeks. Rilonacept is being studied for use in preventing allopurinol-induced gout flares.

Study identification

NCT ID: NCT00829829
Recruitment status: Completed
Study type: Interventional
Phase: Phase 3
Lead sponsor: Regeneron Pharmaceuticals; Industry
Enrollment: 241 participants

Conditions and interventions

Conditions

Intercritical Gout

Interventions

Other · Drug

Eligibility (public fields only)

Age range: 18 Years to 80 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Feb 2009 (Type not available)
Primary completion: May 2010 (Actual)
Completion: Jun 2010 (Actual)
Last update posted: Apr 28, 2017

2009 – 2010

United States locations

U.S. sites: 67
U.S. states: 27
U.S. cities: 64

Facility	City	State	ZIP	Site status
Not listed	Birmingham	Alabama	35294	—
Not listed	Gilbert	Arizona	85296	—
Not listed	Peoria	Arizona	85381	—
Not listed	Searcy	Arkansas	72143	—
Not listed	Concord	California	94520	—
Not listed	San Diego	California	92103	—
Not listed	Santa Maria	California	93454	—
Not listed	Trumball	Connecticut	06611	—
Not listed	Washington D.C.	District of Columbia	20003	—
Not listed	Daytona Beach	Florida	32117	—
Not listed	Delray Beach	Florida	33446	—
Not listed	Jacksonville	Florida	32205	—
Not listed	Jupiter	Florida	33458	—
Not listed	Naples	Florida	34102	—
Not listed	St. Petersburg	Florida	33702	—
Not listed	Gainsville	Georgia	30501	—
Not listed	Rome	Georgia	30165	—
Not listed	Tucker	Georgia	30084	—
Not listed	Woodstock	Georgia	30188	—
Not listed	Boise	Idaho	83713	—
Not listed	Avon	Indiana	46123	—
Not listed	Evansville	Indiana	47714	—
Not listed	South Bend	Indiana	46601	—
Not listed	Wichita	Kansas	67208	—
Not listed	Bowling Green	Kentucky	42101	—
Not listed	Owensboro	Kentucky	42303	—
Not listed	Baltimore	Maryland	21286	—
Not listed	Ellicott City	Maryland	21042	—
Not listed	Resistertown	Maryland	01136	—
Not listed	Troy	Michigan	48098	—
Not listed	Jackson	Mississippi	39202	—
Not listed	Florissant	Missouri	63031	—
Not listed	Las Vegas	Nevada	89123	—
Not listed	Las Vegas	Nevada	89146	—
Not listed	Berkeley Heights	New Jersey	07922	—
Not listed	Freehold	New Jersey	07728	—
Not listed	Brooklyn	New York	11201	—
Not listed	Greensboro	North Carolina	27408	—
Not listed	Hickory	North Carolina	28601	—
Not listed	Morehead City	North Carolina	28516	—
Not listed	Raleigh	North Carolina	27607	—
Not listed	Raleigh	North Carolina	27612	—
Not listed	Salisbury	North Carolina	28144	—
Not listed	Akron	Ohio	44313	—
Not listed	Cincinnati	Ohio	45246	—
Not listed	Middleburg Heights	Ohio	44130	—
Not listed	Perrysburg	Ohio	43551	—
Not listed	Duncansville	Pennsylvania	16635	—
Not listed	Fountain Hill	Pennsylvania	18105	—
Not listed	Huntingdon Valley	Pennsylvania	19006	—
Not listed	Lancaster	Pennsylvania	17601	—
Not listed	Charleston	South Carolina	29406	—
Not listed	Columbia	South Carolina	29204	—
Not listed	Greer	South Carolina	29651	—
Not listed	North Charleston	South Carolina	29406	—
Not listed	Rock Hill	South Carolina	29732	—
Not listed	Memphis	Tennessee	38120	—
Not listed	Dallas	Texas	75224	—
Not listed	Dallas	Texas	75231	—
Not listed	Houston	Texas	77074	—
Not listed	Longview	Texas	75605	—
Not listed	Richardson	Texas	75080	—
Not listed	San Antonio	Texas	78229	—
Not listed	Burke	Virginia	22015	—
Not listed	Richmond	Virginia	23219	—
Not listed	Spokane	Washington	99204	—
Not listed	Tacoma	Washington	98405	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00829829, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 28, 2017 · Synced Oct 21, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00829829 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →